Patients Bayer sets out a proposed basis for science-based self-care ... The healthcare sector has a “moral imperative” to help people navigate the self-care industry, says pharma giant.
News Biogen swoops on Apellis with $5.6bn offer In today's second sizeable M&A deal, Biogen has agreed to buy Apellis for around $5.6 billion, building on its aspirations in nephrology.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
